TCL Archive Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint May 31, 2013
TCL Archive Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors July 4, 1997